Unidose Pharma SRL

19.2 FTE

Unidose Pharma reported total assets of €3.90m at the end of the 2025 financial year (annual accounts filed with the NBB on 31 Aug 2026), with 19.2 full-time equivalents.

By total assets for 2025, Unidose Pharma ranks among the 100 largest of the 3,805 companies in its sector (NACE 4773) in Belgium that filed accounts for that financial year. Largest companies in the sector →

Company number (CBE) 0467.278.989 · VAT BE0467278989
8870 Izegem
active in Retail sale of pharmaceutical products (NACE 47730)
operating since 15 Nov 1999 (≈ 27 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Unidose Pharma shows with a free account.

See the score
Profile
SRL Small · 19.2 FTE since 1999
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result223,596 €
Equity889,111 €
Cash110,911 €
EBITDA553,794 €
Total assets€3.90m
Headcount (avg FTE)19.2
The line marks its sector median: 44.2% (2068 companies).

Change 2022 → 2025: Equity +282 % Total assets +12 % Headcount (avg FTE) +7 %

Accounts of the company itself (not consolidated).

The full file covers 10 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Unidose Pharma's annual accounts

20252024202320222021
Net result223,596 €
Equity889,111 €
Cash110,911 €
EBITDA553,794 €
Total assets€3.90m

Filed annual accounts

  • Year ended 31 Dec 2025filed on 31 Aug 2026
  • Year ended 31 Dec 2024filed on 29 Aug 2025
  • Year ended 31 Dec 2023filed on 30 Aug 2024
  • Year ended 31 Dec 2022filed on 30 Aug 2023
  • Year ended 31 Dec 2021filed on 21 Jun 2022

Unidose Pharma's financial analysis

Management and control of Unidose Pharma

8 active director(s) in the register.

and 2 more

Unidose Pharma's shareholders and holdings →

Unidose Pharma's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0467.278.989
VAT number
BE0467278989
Peppol
Registered · 0208:0467278989 · as of 10 Nov 2026
Legal form
SRL
Incorporated
15 Nov 1999
Registered office
8870 Izegem
Size
Small · 19.2 FTE
Latest accounts
2025 · filed on 31 Aug 2026
Activity
Retail sale of pharmaceutical products (NACE 47730)

Unidose Pharma (SRL) has been based in Izegem since 1999, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 223,596 € and equity of 889,111 €; its revenue is not published. With 19.2 full-time equivalents, it is a small enterprise by headcount. Its solvency stands at 22.8%, below the median of its sector (44.2%).

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Unidose Pharma

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Unidose Pharma

What is the revenue of Unidose Pharma?

Unidose Pharma files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of Unidose Pharma?

In Belgium, the VAT number is the company number prefixed with BE: BE0467278989 for Unidose Pharma, if the company is VAT-registered. Its company number (CBE) is 0467.278.989.

Where is the registered office of Unidose Pharma?

According to the CBE register, the registered office of Unidose Pharma is in 8870 Izegem.

What is the equity of Unidose Pharma?

At the close of the 2025 financial year, the equity of Unidose Pharma amounts to 889,111 €, a solvency of 22.8% of total assets.

How many people work at Unidose Pharma?

19.2 full-time equivalents on average according to the 2025 social balance sheet.

Who manages Unidose Pharma?

The register lists 8 active mandates at Unidose Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

How large is Unidose Pharma within its sector?

By total assets for 2025, Unidose Pharma ranks among the 100 largest of the 3,805 companies in its sector (NACE 4773) in Belgium that filed accounts for that financial year.

Idonis

The full file of Unidose Pharma

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 06 Sep 2026

No credit card, no commitment.

What each plan unlocks →